Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Express Scripts
McKinsey
Harvard Business School
Queensland Health
Moodys
Accenture
Cipla

Generated: June 24, 2018

DrugPatentWatch Database Preview

PHENDIMETRAZINE TARTRATE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for phendimetrazine tartrate and what is the scope of phendimetrazine tartrate patent protection?

Phendimetrazine tartrate
is the generic ingredient in nineteen branded drugs marketed by Valeant, Numark, Graham Dm, Virtus Pharms, Shire Richwood, Mast Mm, Sandoz, Vitarine, Solvay, Teva, Ferndale Labs, Abc Holding, Camall, Chartwell Rx, Pvt Form, Forest Pharms, Barr, Elite Labs Inc, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Usl Pharma, Watson Labs, and Wyeth Ayerst, and is included in ninety-six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for phendimetrazine tartrate. Twenty-three suppliers are listed for this compound.
Summary for PHENDIMETRAZINE TARTRATE
US Patents:0
Tradenames:19
Applicants:29
NDAs:96
Drug Master File Entries: 5
Suppliers / Packagers: 23
DailyMed Link:PHENDIMETRAZINE TARTRATE at DailyMed
Pharmacology for PHENDIMETRAZINE TARTRATE

US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 088063-001 Sep 10, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Numark SPRX-105 phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 088024-001 Dec 22, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086370-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva STATOBEX phendimetrazine tartrate CAPSULE;ORAL 085507-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Teva
McKesson
Deloitte
Colorcon
Healthtrust
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.